Format

Send to

Choose Destination
Endocrinol Metab Clin North Am. 2019 Jun;48(2):429-440. doi: 10.1016/j.ecl.2019.01.005.

Dermatologic Conditions in Transgender Populations.

Author information

1
Department of Dermatology, Emory University School of Medicine, 1525 Clifton Road NE, Suite 100, Atlanta, GA 30322, USA; Regional Telehealth Services, Veterans Integrated Service Network 7, 250 N Arcadia Avenue, Decatur, GA 30030, USA. Electronic address: howa.yeung@emory.edu.
2
Department of Dermatology, Emory University School of Medicine, 1525 Clifton Road NE, Suite 100, Atlanta, GA 30322, USA.
3
Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, 101 Woodruff Circle Northeast, WRMB 1301, Atlanta, GA 30322, USA; Atlanta VA Medical Center, 1670 Clairmont Road Northeast, Decatur, GA 30300, USA.

Abstract

Transgender persons receiving gender-affirming hormone therapy and procedures may face specific skin conditions. Skin diseases in transgender patients often are underdiagnosed and underrecognized despite their important impact on quality of life and mental health. This article discusses pathophysiology, diagnosis, and treatment of common skin diseases in the transgender populations. For transmasculine patients, conditions include acne vulgaris and male pattern hair loss. For transfeminine patients, conditions include hirsutism, pseudofolliculitis barbae, and melasma. Postprocedural keloids and other cutaneous complications are discussed. Unique aspects of skin health in transgender persons should be considered in the context of multidisciplinary gender-affirming care.

KEYWORDS:

Acne; Dermatology; Gender affirmation; Hair loss; Hirsutism; Keloid; Transgender

PMID:
31027550
PMCID:
PMC6497076
[Available on 2020-06-01]
DOI:
10.1016/j.ecl.2019.01.005

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center